Chandramani Singh

Chandramani Singh

Auto-generated profile, based on publicly available information

Chandramani Singh

All India Institute of Medical Science, Patna

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2022 in EBioMedicine
Verified
Journal Article
Open access
STSubhash Thuluva
Subhash Thuluva
VPVikram Paradkar
Vikram Paradkar
SGSubba Reddy Gunneri
Subba Reddy Gunneri
VYVijay Yerroju
Vijay Yerroju
RMRammohan Reddy Mogulla
Rammohan Reddy Mogulla
VAVenkateshwar Rao A
Venkateshwar Rao A
We assessed the efficacy of a receptor-binding domain (RBD)-based protein subunit COVID-19 vaccine. A randomised Phase-1/2 trial followed by a Phase-2 trial were conducted to assess the safety and immunogenicity of the COVID-19 vaccine Corbevax and select to an optimum formulation. Healthy adults (n=460) without COVID-19 vaccination or SARS-CoV-2 infection in the Phase-1/2 study were randomly divided into four vaccine formulation groups. A low incidence of adverse events was reported post-vaccination. All formulations showed similar profiles of humoral and cellular immune responses that were associated with the content of CpG1018 adjuvant in the vaccine. In the Phase-2 study, 750 µg of CpG1018 showed significant improvement (> 4-fold increase from baseline) in immune responses, including the titres of anti-RBD IgG and neutralising antibody (nAb), and cellular immune responses, while maintaining the safety profile. Antibodies persisted consistently for 12 months after the second dose of vaccine. Corbevax (two-dose schedule with 28 days of interval between doses) was well tolerated with no observed safety concerns. Previous observations from efficacy studies by Moderna and AstraZeneca and the correlation between nAb titres post-vaccination and a human convalescent serum panel showed that Corbevax induced significantly high nAb titres. These studies were prospectively registered with the Clinical Trial Registry of India (CTRI/2021/06/034014 and CTRI/2020/11/029032). Bill & Melinda Gates Foundation, BIRAC-Division of Department of Biotechnology, Govt of India, and the Coalition for Epidemic Preparedness Innovations funded this study.

11 October 2021 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
CSChandramani Singh
Chandramani Singh
BNBijaya Nanda Naik
Bijaya Nanda Naik
SPSanjay Pandey
Sanjay Pandey
BBBijit Biswas
Bijit Biswas
BPBinod Kumar Pati
Binod Kumar Pati
PSPrabhat Kumar Singh
Prabhat Kumar Singh
Effectiveness of corona virus disease-19 (COVID-19) vaccines used in India is unexplored and need to be substantiated. The present case-control study was planned to elicit the effectiveness of COVID-19 vaccines in preventing infection and disease severity in the general population of Bihar, India. This case-control study was conducted among people aged ≥45 years during April to June 2021. The cases were the COVID-19 patients admitted or visited All India Institute of Medical Sciences (AIIMS), Patna, Bihar, India, and were contacted directly. The controls were the individuals tested negative for severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) at the Virology laboratory, AIIMS-Patna and contacted telephonically for collection of relevant information. The vaccine effectiveness (VE) was calculated by using the formula (VE = 1 – odds ratio). The adjusted VE for partial and full vaccination were estimated to be 52.0% (95% confidence interval (CI) 39.0–63.0%) and 83.0% (95% CI 73.0–89.0%) respectively for preventing SARS CoV-2 infection. The sub-group analyses of the cases have shown that the length of hospital stays (LOS) (partially vaccinated: 9 days vs. unvaccinated: 12 days; P = 0.028) and the severity of the disease (fully vaccinated: 30.3% vs. partially vaccinated: 51.3% and unvaccinated: 54.1%; P = 0.035) were significantly low among vaccinated compared to unvaccinated individuals. To conclude, four out of every five fully vaccinated individuals are estimated to be protected from contracting SARS CoV-2 infection. Vaccination lowered LOS and chances of development of severe disease.

31 March 2022 in Nepal Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
SNSantosh Kumar Nirala
Santosh Kumar Nirala
BNBijaya Naik
Bijaya Naik
RRRajath Rao
Rajath Rao
SPSanjay Pandey
Sanjay Pandey
CSChandramani Singh
Chandramani Singh
NCNeha Chaudhary
Neha Chaudhary
Background: The emergence of the COVID-19 pandemic and lockdown measures to confine it has disrupted the routine of the public. The impact of such long-term confinements on the lifestyle and diet of students are not known and hence this study was designed to assess the impact of lockdown due to the COVID-19 pandemic on the lifestyle and diet of university students. Methods: An online cross-sectional survey among 622 university students across various educational institutes of east India using a pre-designed questionnaire about lifestyle-diet before and during the lockdown. Results were tabulated and statistical tests like Paired t-test, Wilcoxon Rank sign test, and Mc-Nemar tests were applied and overall significance was attributed to P<0.05. Results: During the lockdown a total of 2.4% (95% CI: 1.4-3.8%) decrease in prevalence of tobacco use, 8.7% (95% CI: 6.6-11%) decrease in physical activity and a 0.8 hour (95% CI: 0.6-0.9 hour) increase in the mean sleep duration was observed. There was a significant increase in use of fresh fruits consumption [Median(IQR)-before:2(1-5);during:3(1-5) days] and a decrease in meat-poultry[Median(IQR)-before: 2(0-3);during: 1(0-3)days] and junk food[Median(IQR)-before:1(0-2);during:0(0-2)days] consumption during the lockdown. Conclusion: A significant proportion of changes in lifestyle and frequency of consumption of certain food items in the dietary pattern during the lockdown.

30 July 2021 in Clinical Epidemiology and Global Health
Verified
Journal Article
Open access
BNBijaya Nanda Naik
Bijaya Nanda Naik
BBBijit Biswas
Bijit Biswas
CSChandramani Singh
Chandramani Singh
SPSanjay Pandey
Sanjay Pandey
SNSantosh Kumar Nirala
Santosh Kumar Nirala
NCNeha Chaudhary
Neha Chaudhary
Healthcare professionals (HCPs) have a definite role in tobacco control and can help immensely by setting examples. The current study aimed to study the tobacco use pattern and quitting behaviour among HCPs of India during the COVID-19 pandemic. We addressed the research objective using a cross-sectional, anonymous online survey using ‘google form” among 687 HCPs of India during December 2020. Descriptive and inferential statistics were performed using SPSS. Overall, 32.6% of the HCPs were ever tobacco user while 23.4% and 16.9% were current and daily tobacco user. During the COVID-19 pandemic, 51.7% and 43.1% of HCPs cut down the frequency and amount of tobacco use respectively while for 24.1% COVID-19 pandemic exerted no effect on their tobacco use. Presence of vulnerable population at home [ adjusted odds ratio (AOR): 17.5 (95% confidence interval (CI): 3.3–92.2)], ever tobacco quit attempt [AOR: 13.5 (95% CI:2.7–67.7)] and history of COVID-19 disease [AOR: 5.1 (95% CI:1.3–20.7)] significantly determined reduced tobacco use (60.3%) during the pandemic. Similarly, reduced tobacco use during the pandemic [AOR: 4.8 (95% CI:1.7–13.5)] and perception of both smoking and smokeless tobacco form to be harmful for COVID-19 [AOR: 4.8 (95% CI:1.7–13.5)] were the independent correlates of tobacco quit attempt (50.0%) during the pandemic. Tobacco use was quite rampant among the HCPs with every fourth and sixth being a current and daily tobacco user respectively. During the COVID-19 pandemic three in every five HCPs surveyed reduced tobacco use while every second HCP made a quit attempt.

31 March 2020 in Indian Journal of Community Health
Verified
Journal Article
Open access
PDF file
PKPragya Kumar
Pragya Kumar
ARAlok Ranjan
Alok Ranjan
DKDhananjay Kumar
Dhananjay Kumar
SPSanjay Pandey
Sanjay Pandey
CSC M Singh
C M Singh
NANeeraj Agarwal
Neeraj Agarwal
Background: Brick kiln workers are unskilled labourers and keep migrating from one place to another leading to non/partial immunization of their children. The study was conducted to estimate the prevalence of full immunisation among the children of mother living in brick kiln and to assess the factors associated with incomplete or non-immunisation. Methods: The study was conducted using stratified cluster sampling technique in different brick kilns of four districts of Bihar. Results: Out of 332 children the prevalence of full immunization was 55.43% and partial immunization was 37.65% while 6.92 % children were not immunized at all. The most common reason for non/partial immunization was lack of awareness about importance of immunization (37.2%) followed by no information of nearest place of vaccination (33.1%). Conclusion: The routine immunization coverage has increased but it is still low among migrant brick kiln workers.

31 March 2020 in Indian Journal of Community Health
Verified
Journal Article
Open access
PDF file
CSC M Singh
C M Singh
AMAbhishek Mishra
Abhishek Mishra
NANeeraj Agarwal
Neeraj Agarwal
AAArshad Ayub
Arshad Ayub
SMShradha Mishra
Shradha Mishra
PLPallavi Lohani
Pallavi Lohani
Background: Routine childhood immunization has proven to be among the most practical and most cost-effective health interventions. The full immunization coverage (FIC) has increased, still it is less. Especially in the low performing blocks of Bihar ,it is less than 70 %.There are various factors responsible for less FIC including gender discrimination also which is still hidden in the society. Hence this study was done to find out the FIC in Bihar with associated factors including gender discrimination. Objectives: To find out the various associated factors affecting FIC and to find out gender discrimination (if any) in FIC in different districts of Bihar. Methodology: Two stage cluster sampling with Probability Proportional to size Sampling (PPS) was used as per Study protocol. The study was conducted in 59 low- performing blocks of Bihar where the full immunization coverage was less than 70%. The survey was conducted in 59 blocks. From each block, 30 clusters (Villages) were selected. As a convention, 7 children of age group 12- 23 months were selected from each cluster. Thus, data collection was done for a total of 12,390 children.A structured questionnaire was formulated on the basis of WHO coverage evaluation format. Web based Application SDRC kit was used for data collection while SPSS v. 20 was used for analysis. Results: FIC was found to be 60.81% , it was higher for the rural clusters, general caste, Hindus when compared to urban clusters , SC and other castes, and Muslim religion respectively. For 1st child FIC was highest (66.8%) and was lesser for females. A coverage ratio (female to male) was found to be less than 1 for most of the districts. Conclusion: There are considerable inequities in full immunization by various individual (birth order, gender, birth weight), social (religion, caste), and societal (health care facility and cluster type) characteristics. In general, the ratio (female/male) remains less than 1 for most of the districts.